Early DMO: a predictor of poor outcomes following cataract surgery in diabetic patients. The DICAT-II study.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
01
03
2021
accepted:
22
07
2021
revised:
28
06
2021
pubmed:
5
8
2021
medline:
27
7
2022
entrez:
4
8
2021
Statut:
ppublish
Résumé
The prospective DIabetes and CATaract Study II (DICAT II) was performed to characterise the risks of cataract surgery to the retinae of patients with early diabetic macular oedema (E-DMO). DICAT II was a prospective, comparative, multicentre, observational study involving six Italian clinics. Patients were aged ≥55 years, had type 1 or 2 diabetes with spectral-domain optical coherence tomography evidence of ESASO classification Early DMO. Group 1 eyes (78 eyes, 78 patients) underwent phacoemulsification-based cataract surgery. Group 2 eyes (65 eyes, 65 patients) had E-DMO and either clear media or had undergone uncomplicated cataract surgery ≥1 year previously. Central subfield thickness (CST) and best-corrected visual acuity (BCVA) were assessed in both groups. The negative impact of surgery on CST was evident after the first postoperative week; CST peaked during the first month, then rapidly decreased. CST worsening ≥10 µm was observed in 63/78 eyes (80.7%) and 29/65 eyes (44.6%) in Groups 1 and 2, respectively (p < 0.0001). CST worsening of ≥50 µm was observed in 51 eyes (65.4%) and 10 eyes (15.4%) in Groups 1 and 2, respectively (p < 0.0001). Mean CST worsening was lower in Group 2 than in Group 1 (38.6 ± 30.4 µm vs 85.5 ± 55.3 µm, p < 0.0001) with a lower BCVA loss (-2.6 ± 3.5 letters vs -8.2 ± 6.2 letters, p < 0.0001). Higher glycaemic levels and HBA1c levels were significantly associated with the risk of >50 μm CST worsening in eyes from both groups. Early DMO is associated with poorer outcomes after cataract surgery and requires close pre- and postoperative monitoring.
Sections du résumé
BACKGROUND
The prospective DIabetes and CATaract Study II (DICAT II) was performed to characterise the risks of cataract surgery to the retinae of patients with early diabetic macular oedema (E-DMO).
METHODS
DICAT II was a prospective, comparative, multicentre, observational study involving six Italian clinics. Patients were aged ≥55 years, had type 1 or 2 diabetes with spectral-domain optical coherence tomography evidence of ESASO classification Early DMO. Group 1 eyes (78 eyes, 78 patients) underwent phacoemulsification-based cataract surgery. Group 2 eyes (65 eyes, 65 patients) had E-DMO and either clear media or had undergone uncomplicated cataract surgery ≥1 year previously. Central subfield thickness (CST) and best-corrected visual acuity (BCVA) were assessed in both groups.
RESULTS
The negative impact of surgery on CST was evident after the first postoperative week; CST peaked during the first month, then rapidly decreased. CST worsening ≥10 µm was observed in 63/78 eyes (80.7%) and 29/65 eyes (44.6%) in Groups 1 and 2, respectively (p < 0.0001). CST worsening of ≥50 µm was observed in 51 eyes (65.4%) and 10 eyes (15.4%) in Groups 1 and 2, respectively (p < 0.0001). Mean CST worsening was lower in Group 2 than in Group 1 (38.6 ± 30.4 µm vs 85.5 ± 55.3 µm, p < 0.0001) with a lower BCVA loss (-2.6 ± 3.5 letters vs -8.2 ± 6.2 letters, p < 0.0001). Higher glycaemic levels and HBA1c levels were significantly associated with the risk of >50 μm CST worsening in eyes from both groups.
CONCLUSION
Early DMO is associated with poorer outcomes after cataract surgery and requires close pre- and postoperative monitoring.
Identifiants
pubmed: 34345028
doi: 10.1038/s41433-021-01718-4
pii: 10.1038/s41433-021-01718-4
pmc: PMC8330474
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1687-1693Informations de copyright
© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
Références
International Diabetes Federation. IDF Diabetes Atlas Ninth Edition. https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf (2019). Accessed 20 June 2021.
Selvin E, Coresh J, Brancati FL. The burden and treatment of diabetes in elderly individuals in the U.S. Diabetes Care. 2006;29:2415–9.
doi: 10.2337/dc06-1058
Wang Q, Zhang X, Fang L, Guan Q, Guan L, Li Q. Prevalence, awareness, treatment and control of diabetes mellitus among middle-aged and elderly people in a rural Chinese population: a cross-sectional study. PLoS One. 2018;13:e0198343.
doi: 10.1371/journal.pone.0198343
Pollreisz A, Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:608751.
pubmed: 20634936
pmcid: 2903955
International Diabetes Federation. Clinical practice recommendations for managing diabetic macular edema. https://www.idf.org/component/attachments/?task=download&id=2153 (2019). Accessed 20 June 2021.
Shin ES, Sorenson CM, Sheibani N. Diabetes and retinal vascular dysfunction. J Ophthalmic Vis Res. 2014;9:362–73.
pubmed: 25667739
pmcid: 4307665
Panozzo G, Staurenghi G, Dalla Mura G, Giannarelli D, Alessio G, Alongi S, et al. Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study. Eur J Ophthalmol. 2020;30:315–20.
doi: 10.1177/1120672119830578
Dowler JG, Hykin PG, Lightman SL, Hamilton AM. Visual acuity following extracapsular cataract extraction in diabetes: a meta-analysis. Eye (Lond). 1995;9:313–7. Pt 3
doi: 10.1038/eye.1995.61
Gupta A, Gupta V. Diabetic maculopathy and cataract surgery. Ophthalmol Clin North Am. 2001;14:625–37.
doi: 10.1016/S0896-1549(05)70262-5
Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC. Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology. 2016;123:316–23.
doi: 10.1016/j.ophtha.2015.10.001
Panozzo G, Cicinelli MV, Augustin AJ, Battaglia Parodi M, Cunha-Vaz J, Guarnaccia G, et al. An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification. Eur J Ophthalmol. 2020;30:8–18.
doi: 10.1177/1120672119880394
ETDRS Group. Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified airlie house classification: ETDRS Report Number 10. Ophthalmol. 1991;98:786–806.
doi: 10.1016/S0161-6420(13)38012-9
Yüksel B, Karti Ö, Kusbeci T. Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives. Clin Ophthalmol. 2017;11:2183–90.
doi: 10.2147/OPTH.S132810
Furino C, Boscia F, Niro A, D’Addario M, Grassi MO, Saglimbene V, et al. Diabetic macular edema and cataract surgery: phacoemulsification combined with dexamethasone intravitreal implant compared with standard phacoemulsification. Retina. 2021;41:1102–9.
doi: 10.1097/IAE.0000000000002974
Rauen PI, Ribeiro JA, Almeida FP, Scott IU, Messias A, Jorge R. Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema. Retina. 2012;32:1799–803.
doi: 10.1097/IAE.0b013e31824bebb8
Goh JKS, Lim LL. Dealing with co-existent cataract and diabetic macular oedema: an increasingly common conundrum now solved? Clin Exp Ophthalmol. 2020;48:424–6.
doi: 10.1111/ceo.13764
Baker CW, Almukhtar T, Bressler NM, Glassman AR, Grover S, Kim SJ, et al. Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. JAMA Ophthalmol. 2013;131:870–9.
doi: 10.1001/jamaophthalmol.2013.2313
Chen XY, Song WJ, Cai HY, Zhao L. Macular edema after cataract surgery in diabetic eyes evaluated by optical coherence tomography. Int J Ophthalmol. 2016;9:81–5.
doi: 10.17816/OV9281-99
Bressler SB, Baker CW, Almukhtar T, Bressler NM, Edwards PA, Glassman AR, et al. Pilot study of individuals with diabetic macular edema undergoing cataract surgery. JAMA Ophthalmol. 2014;132:224–6.
doi: 10.1001/jamaophthalmol.2013.6209